Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma

Background: Proton beam has an excellent depth dose distribution due to its unique physical properties, and thus proton beam therapy (PBT) has been tried and showed promising outcomes in hepatocellular carcinoma (HCC). The purpose of this phase II study is to evaluate the efficacy of hypofractionate...

Full description

Bibliographic Details
Main Authors: Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, Eun Sang Oh, Sang Hee Youn, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Dae Yong Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Oncology
Subjects:
hepatocellular carcinoma
overall survival
local progression-free survival
proton beam therapy
radiotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00542/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00542/full

Similar Items